Episode 4 - Spotted This Week in Healthcare

Episode #4 - Spotted - This Week in Healthcare



It's time for the healthcare weekly round-up 🤝


📌 Welcome to Edition #4 of "Spotted! - This Week in Healthcare".


Each week I will share the interesting things that I spotted in the world of healthcare.



So, here we go...


Edition #4

--------

According to Leslie Schrock - "2024 is the year male fertility startups go mainstream".


Why?


Well, men are responsible for around half of all infertility, yet a quarter of men are still not tested or treated during an infertility examination.


Also, Leslie pointed out that studies suggest around 1 in 5 couples who go through IVF later conceive naturally, which means that the lack of male treatment likely leads to overtreatment for women.


So really women are serving as treatment surrogates for men, and until that changes, male fertility is a women’s health problem. Isn't it?


According to one report, the global male infertility market hit $4 billion in 2022 and it will climb to nearly $6 billion by 2030.


This is a must read post, and it comes with a Market Map of Fertility Startups.

Check it out -

https://lnkd.in/eGptw8_Z

--------

Next up, we have a company called Legacy.


Legacy is America’s largest at-home fertility clinic for people with sperm, empowering individuals to learn more about their sperm and proactively plan for their future with secure sperm freezing options.


Partnering with leading health plans, fertility benefits providers, US military programs, and financing merchants, Legacy is making industry-leading sperm testing and freezing affordable and accessible.


Check out Legacy

--------

OB-GYN Dr. Dr. Thais Aliabadi recommends that young patients consider genetic testing if they have a family history of cancer.


Please do not skip genetic testing, hear from Dr. Aliabadi directly in this clip at Fortune here -

https://lnkd.in/eMJibACZ

--------

Last one is an advice for health-tech VCs from Christina Farr.


She tweeted -


"If it makes anyone feel better to hear this, most founders raising money right now in health-tech are taking upwards of 100 investor meetings.


In some cases, 300+. This is a LOT of time.


 VCs, you can probably be most helpful rn just not taking the meeting if you're not deploying or you're very unlikely to invest"

--------

And that wraps up the 4th exciting edition!


Tune in next week for more buzz from the health-tech world.

Have a fantastic weekend, everyone!

Share by: